Skip to content

Clinical trials

Observational Demyelinating Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Demyelinating Diseases Phase: Observational Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20091
20101
20111
20151
20181
20201
20212
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)2
Baylor Research Institute1
Dragonfly Research, LLC1
EMD Serono1
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul1
Shire1
SwanBio Therapeutics, Inc.1
The University of Texas Health Science Center, Houston1
University of California, San Francisco1
University of South Florida1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Demyelinating Diseases12
Multiple Sclerosis7
Nervous System Diseases4
Autoimmune Diseases3
Immune System Diseases3
Lysosomal Storage Diseases3
Autoimmune Diseases of the Nervous System2
Brain Diseases, Metabolic, Inborn2
Demyelinating Autoimmune Diseases, CNS2
Hereditary Central Nervous System Demyelinating Diseases2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.